Lobbying activity

1A

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate

Tariff (miscellaneous tariff bills), Agriculture, Budget/Appropriations, Copyright/Patent/Trademark

View → 4A

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate

Natural Resources, Environment/Superfund, Labor Issues/Antitrust/Workplace, Foreign Relations

View → Q2

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code

View → Q2

EMD SERONO, INC. for EMD SERONO INC

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues, Medicare/Medicaid

View → Q2

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Trade (domestic/foreign), Budget/Appropriations, Copyright/Patent/Trademark, Health Issues

View → Q2

BIOGEN for BIOGEN

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code

View → Q2

BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Agriculture, Budget/Appropriations, Copyright/Patent/Trademark, Health Issues

View → Q2

DLA PIPER LLP (US) for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Copyright/Patent/Trademark, Budget/Appropriations, Defense, Trade (domestic/foreign)

View → Q2

DLA PIPER LLP (US) for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (domestic/foreign), Health Issues

View → Q2

FORBES-TATE for NOVARTIS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Budget/Appropriations

View → Q2

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate

Defense, Health Issues, Budget/Appropriations, Copyright/Patent/Trademark

View → Q2

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q2

SOLENO THERAPEUTICS, INC. for SOLENO THERAPEUTICS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate

Pharmacy, Trade (domestic/foreign), Financial Institutions/Investments/Securities, Health Issues

View → Q2

WILLIAMS AND JENSEN, PLLC for PHRMA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Budget/Appropriations, Defense, Trade (domestic/foreign), Medicare/Medicaid

View → Q2

MONUMENT ADVOCACY for PHRMA

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $90,000.00 income

Trade (domestic/foreign), Foreign Relations, Health Issues

View → Q2

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Health Issues, Medicare/Medicaid, Animals

View → Q2

THE ALS ASSOCIATION for THE ALS ASSOCIATION

2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate

Welfare, Aviation/Airlines/Airports, Small Business, Budget/Appropriations

View → Q2

NOVARTIS for NOVARTIS

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid

View → Q2

TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Budget/Appropriations, Medicare/Medicaid, Health Issues, Trade (domestic/foreign)

View → Q2

NEUROCRINE BIOSCIENCES, INC for NEUROCRINE BIOSCIENCES, INC

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate

Medicare/Medicaid, Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code

View → Q2

PUBLIC CITIZEN for PUBLIC CITIZEN

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate

Consumer Issues/Safety/Products, Financial Institutions/Investments/Securities, Banking, Civil Rights/Civil Liberties

View → Q2

THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code

View → Q2

CROSSROADS STRATEGIES, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income

Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q2

ADVANCED POLICY CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $40,000.00 income

Health Issues

View → Q2

TODD STRATEGY GROUP for NOVARTIS, INC.

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income

Health Issues, Medicare/Medicaid, Trade (domestic/foreign)

View →